CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 743 of 865
Non-Antibody Products
Page 743 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Shield-1 | A protein stabilizing ligand; inhibits decreases in fluorescence in NIH3T3… | 1 mg | 37325-1 | More Info |
| Shield-1 | A protein stabilizing ligand; inhibits decreases in fluorescence in NIH3T3… | 10 mg | 37325-10 | More Info |
| Shield-1 | A protein stabilizing ligand; inhibits decreases in fluorescence in NIH3T3… | 5 mg | 37325-5 | More Info |
| Shikalkin | A naphthoquinone and racemic mixture of alkannin and shikonin | 10 mg | 34355-10 | More Info |
| Shikalkin | A naphthoquinone and racemic mixture of alkannin and shikonin | 100 mg | 34355-100 | More Info |
| Shikalkin | A naphthoquinone and racemic mixture of alkannin and shikonin | 50 mg | 34355-50 | More Info |
| Shikimic Acid | A cyclohexenecarboxylic acid; an intermediate in the biosynthesis of aroma… | 1 g | 26851-1 | More Info |
| Shikimic Acid | A cyclohexenecarboxylic acid; an intermediate in the biosynthesis of aroma… | 250 mg | 26851-250 | More Info |
| Shikimic Acid | A cyclohexenecarboxylic acid; an intermediate in the biosynthesis of aroma… | 5 g | 26851-5 | More Info |
| Shikimic Acid | A cyclohexenecarboxylic acid; an intermediate in the biosynthesis of aroma… | 500 mg | 26851-500 | More Info |
| Shikonin | A naturally occurring naphthoquinine; increases glucose uptake by adipocyt… | 10 mg | 14751-10 | More Info |
| Shikonin | A naturally occurring naphthoquinine; increases glucose uptake by adipocyt… | 100 mg | 14751-100 | More Info |
| Shikonin | A naturally occurring naphthoquinine; increases glucose uptake by adipocyt… | 5 mg | 14751-5 | More Info |
| Shikonin | A naturally occurring naphthoquinine; increases glucose uptake by adipocyt… | 50 mg | 14751-50 | More Info |
| SHIN 1 | An SHMT1 and SHMT2 inhibitor (IC50s = 5 and 13 nM, respectively); inhibits… | 1 mg | 35715-1 | More Info |
| SHIN 1 | An SHMT1 and SHMT2 inhibitor (IC50s = 5 and 13 nM, respectively); inhibits… | 10 mg | 35715-10 | More Info |
| SHIN 1 | An SHMT1 and SHMT2 inhibitor (IC50s = 5 and 13 nM, respectively); inhibits… | 25 mg | 35715-25 | More Info |
| SHIN 1 | An SHMT1 and SHMT2 inhibitor (IC50s = 5 and 13 nM, respectively); inhibits… | 5 mg | 35715-5 | More Info |
| 13(S)-HODE | 13(S)-HODE is produced by incubation of linoleic acid with plant and mamma… | 100 µg | 38610-100 | More Info |
| 13(S)-HODE | 13(S)-HODE is produced by incubation of linoleic acid with plant and mamma… | 25 µg | 38610-25 | More Info |
| 13(S)-HODE | 13(S)-HODE is produced by incubation of linoleic acid with plant and mamma… | 250 µg | 38610-250 | More Info |
| 13(S)-HODE | 13(S)-HODE is produced by incubation of linoleic acid with plant and mamma… | 50 µg | 38610-50 | More Info |
| 9(S)-HODE | A metabolite of linoleic acid; increases transactivation of PPARα an… | 1 mg | 38410-1 | More Info |
| 9(S)-HODE | A metabolite of linoleic acid; increases transactivation of PPARα an… | 100 µg | 38410-100 | More Info |
| 9(S)-HODE | A metabolite of linoleic acid; increases transactivation of PPARα an… | 500 µg | 38410-500 | More Info |
| 13(S)-HODE-biotin | 13(S)-HODE is the LO metabolite of linoleic acid. 13(S)-HODE modulates the… | 1 mg | 38612-1 | More Info |
| 13(S)-HODE-biotin | 13(S)-HODE is the LO metabolite of linoleic acid. 13(S)-HODE modulates the… | 100 µg | 38612-100 | More Info |
| 13(S)-HODE-biotin | 13(S)-HODE is the LO metabolite of linoleic acid. 13(S)-HODE modulates the… | 500 µg | 38612-500 | More Info |
| 9(S)-HODE-13C18 | An internal standard for the quantification of 9-HODE by GC- or LC-MS | 100 µg | 31160-100 | More Info |
| 9(S)-HODE-13C18 | An internal standard for the quantification of 9-HODE by GC- or LC-MS | 25 µg | 31160-25 | More Info |
| 9(S)-HODE-13C18 | An internal standard for the quantification of 9-HODE by GC- or LC-MS | 50 µg | 31160-50 | More Info |
| 13(S)-HODE cholesteryl ester | 13(S)-HODE cholesteryl ester was originally extracted from atherosclerotic… | 100 µg | 38611-100 | More Info |
| 13(S)-HODE cholesteryl ester | 13(S)-HODE cholesteryl ester was originally extracted from atherosclerotic… | 25 µg | 38611-25 | More Info |
| 13(S)-HODE cholesteryl ester | 13(S)-HODE cholesteryl ester was originally extracted from atherosclerotic… | 50 µg | 38611-50 | More Info |
| 9(S)-HODE cholesteryl ester | 9(S)-HODE cholesteryl ester was originally extracted from atherosclerotic… | 100 µg | 38411-100 | More Info |
| 9(S)-HODE cholesteryl ester | 9(S)-HODE cholesteryl ester was originally extracted from atherosclerotic… | 25 µg | 38411-25 | More Info |
| 9(S)-HODE cholesteryl ester | 9(S)-HODE cholesteryl ester was originally extracted from atherosclerotic… | 50 µg | 38411-50 | More Info |
| 13(S)-HODE-d4 | An internal standard for the quantification of 13-HODE by GC- or LC-MS | 100 µg | 338610-100 | More Info |
| 13(S)-HODE-d4 | An internal standard for the quantification of 13-HODE by GC- or LC-MS | 25 µg | 338610-25 | More Info |
| 13(S)-HODE-d4 | An internal standard for the quantification of 13-HODE by GC- or LC-MS | 50 µg | 338610-50 | More Info |
| 9(S)-HODE-d4 | An internal standard for the quantification of 9-HODE by GC- or LC-MS | 100 µg | 338410-100 | More Info |
| 9(S)-HODE-d4 | An internal standard for the quantification of 9-HODE by GC- or LC-MS | 25 µg | 338410-25 | More Info |
| 9(S)-HODE-d4 | An internal standard for the quantification of 9-HODE by GC- or LC-MS | 50 µg | 338410-50 | More Info |
| 9(S)-HODE-d4 MaxSpec® Standard | A quantitative analytical standard guaranteed to meet MaxSpec® identit… | 10 µg | 25368-10 | More Info |
| 13(S)-HODE methyl ester | A neutral, more lipophilic form of the free acid | 1 mg | 10008875-1 | More Info |
| 13(S)-HODE methyl ester | A neutral, more lipophilic form of the free acid | 100 µg | 10008875-100 | More Info |
| 13(S)-HODE methyl ester | A neutral, more lipophilic form of the free acid | 500 µg | 10008875-500 | More Info |
| 10-Shogaol | A phenol with diverse biological activities; selectively inhibits COX-2 ov… | 1 mg | 36171-1 | More Info |
| 10-Shogaol | A phenol with diverse biological activities; selectively inhibits COX-2 ov… | 10 mg | 36171-10 | More Info |
| 10-Shogaol | A phenol with diverse biological activities; selectively inhibits COX-2 ov… | 5 mg | 36171-5 | More Info |
| 6-Shogaol | A minor, bioactive component of ginger with anti-inflammatory and anticanc… | 1 mg | 11901-1 | More Info |
| 6-Shogaol | A minor, bioactive component of ginger with anti-inflammatory and anticanc… | 10 mg | 11901-10 | More Info |
| 6-Shogaol | A minor, bioactive component of ginger with anti-inflammatory and anticanc… | 5 mg | 11901-5 | More Info |
| 8-Shogaol | A polyphenol with diverse biological activities; inhibits TAK1 (IC50 = 5.0… | 1 mg | 40273-1 | More Info |
| 8-Shogaol | A polyphenol with diverse biological activities; inhibits TAK1 (IC50 = 5.0… | 10 mg | 40273-10 | More Info |
| 8-Shogaol | A polyphenol with diverse biological activities; inhibits TAK1 (IC50 = 5.0… | 25 mg | 40273-25 | More Info |
| 8-Shogaol | A polyphenol with diverse biological activities; inhibits TAK1 (IC50 = 5.0… | 5 mg | 40273-5 | More Info |
| 10(S)-HOME | An oxylipin; an intermediate in the conversion of oleic acid to 7,10-dihyd… | 1 mg | 33246-1 | More Info |
| 10(S)-HOME | An oxylipin; an intermediate in the conversion of oleic acid to 7,10-dihyd… | 10 mg | 33246-10 | More Info |
| 10(S)-HOME | An oxylipin; an intermediate in the conversion of oleic acid to 7,10-dihyd… | 5 mg | 33246-5 | More Info |
| Short-chain Fatty Acid MaxSpec® LC-MS Mixture | Contains various short-chain fatty acids (≤12:0); designed for direct u… | 1 ea | 18824-1 | More Info |
| Short-chain Fatty Acid Mixture 1 | A mixture of short-chain and water soluble fatty acids; contains acetic, p… | 5 mL | 28679-5 | More Info |
| Short-chain Fatty Acid Mixture 2 | A mixture of short-chain and water soluble fatty acids; contains acetic, p… | 5 mL | 28680-5 | More Info |
| Short-chain Fatty Acid Mixture 3 | A mixture of ten short-chain and volatile fatty acids; intended for use as… | 100 mL | 28682-100 | More Info |
| 13(S)-HOTrE | 15-LO product of linolenic acid; detected in cell membranes and as the cho… | 1 mg | 39620-1 | More Info |
| 13(S)-HOTrE | 15-LO product of linolenic acid; detected in cell membranes and as the cho… | 100 µg | 39620-100 | More Info |
| 13(S)-HOTrE | 15-LO product of linolenic acid; detected in cell membranes and as the cho… | 500 µg | 39620-500 | More Info |
| 9(S)-HOTrE | A monohydroxy PUFA produced by the actions of 5-LO on α-linolenic ac… | 1 mg | 39420-1 | More Info |
| 9(S)-HOTrE | A monohydroxy PUFA produced by the actions of 5-LO on α-linolenic ac… | 100 µg | 39420-100 | More Info |
| 9(S)-HOTrE | A monohydroxy PUFA produced by the actions of 5-LO on α-linolenic ac… | 500 µg | 39420-500 | More Info |
| 13(S)-HOTrE(γ) | An active metabolite of GLA; inhibits 5-LO (IC50 = 29 µM for the rat… | 1 mg | 39610-1 | More Info |
| 13(S)-HOTrE(γ) | An active metabolite of GLA; inhibits 5-LO (IC50 = 29 µM for the rat… | 100 µg | 39610-100 | More Info |
| 13(S)-HOTrE(γ) | An active metabolite of GLA; inhibits 5-LO (IC50 = 29 µM for the rat… | 25 µg | 39610-25 | More Info |
| 13(S)-HOTrE(γ) | An active metabolite of GLA; inhibits 5-LO (IC50 = 29 µM for the rat… | 500 µg | 39610-500 | More Info |
| SHP099 | An orally bioavailable inhibitor of SHP2 (IC50 = 71 nM); blocks the prolif… | 1 mg | 20000-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile